1. Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis

   • Ennio Lubrano
   • Silvia Scriffignano
   • Fabio Massimo Perrotta

   Commentary Open access 03 July 2023 Pages: 1119 - 1125

   

2. A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis

   • Bruce W. Kirkham
   • Alexander Egeberg
   • Luis Puig

   Review Open access 03 July 2023 Pages: 1127 - 1146

   

3. Infections in Biological and Targeted Synthetic Drug Use in Rheumatoid Arthritis: Where do We Stand? A Scoping Review and Meta-analysis

   • Barbara J. M. Bergmans
   • Biniyam Y. Gebeyehu
   • Esther de Vries

   Original Research Open access 26 June 2023 Pages: 1147 - 1165

   

4. Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK

   • Heide A. Stirnadel-Farrant
   • Sarowar M. Golam
   • Mihail Samnaliev

   Original Research Open access 03 July 2023 Pages: 1167 - 1182

   

5. Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK

   • Heide A. Stirnadel-Farrant
   • Sarowar M. Golam
   • Mihail Samnaliev

   Original Research Open access 03 July 2023 Pages: 1183 - 1197

   

6. Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study

   • Xiaohui Zhang
   • Hong Huang
   • Zhuoli Zhang

   Original Research Open access 07 July 2023 Pages: 1199 - 1213

   

7. Management of Specific Clinical Profiles in Axial Spondyloarthritis: An Expert’s Document Based on a Systematic Literature Review and Extended Delphi Process

   • Rosario García-Vicuña
   • Xavier Juanola
   • Estíbaliz Loza

   Original Research Open access 14 July 2023 Pages: 1215 - 1240

   

8. Racial and Ethnic Disparities in Treatment Initiation Among Patients with Newly Diagnosed Psoriatic Arthritis: A Retrospective Medicaid Claims Database Study

   • Aarti A. Patel
   • Shannon Allen Ferrante
   • Arlene Tieng

   Original Research Open access 15 July 2023 Pages: 1241 - 1253

   

9. Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis

   • Gerd R. Burmester
   • Laura C. Coates
   • Cassandra Kinch

   Original Research Open access 17 July 2023 Pages: 1255 - 1276

   

10. The Impact of Label Changes (Boxed Warning) on Real-World Febuxostat Utilization in Patients with Gout: A Cross-Sectional Drug Utilization Study

    • Alexandra Z. Sosinsky
    • Yufei Song
    • Matt Page

    Original Research Open access 17 July 2023 Pages: 1277 - 1295

    

11. Is the Rate of Responders to Hyaluronic Acid Injection for Patients with Knee Osteoarthritis Stable Over Time? Post hoc Analyses of a 6-Month Follow-Up Study

    • Olivier Bruyere
    • Germain Honvo
    • Bernard Cortet

    Original Research Open access 21 July 2023 Pages: 1297 - 1303

12. Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States

    • Jacob N. Hunnicutt
    • Mary Elizabeth Georgiou
    • Kerry Gairy

    Original Research Open access 21 July 2023 Pages: 1305 - 1318

    

13. Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study

    • Beatriz Joven
    • Raquel Hernández Sánchez
    • Mercedes Núñez

    Original Research Open access 23 July 2023 Pages: 1319 - 1333

    

14. Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate

    • Yoshiya Tanaka
    • Peter C. Taylor
    • Tsutomu Takeuchi

    Original Research Open access 25 July 2023 Pages: 1335 - 1348

    

15. Patients’ Needs Concerning Patient Education in Axial Spondyloarthritis: A Qualitative Study

    • Yvonne M. van der Kraan
    • Davy Paap
    • Anneke Spoorenberg

    Original Research Open access 31 July 2023 Pages: 1349 - 1368

16. PDCD5 as a Potential Biomarker for Improved Prediction of the Incidence and Remission for Patients with Rheumatoid Arthritis

    • Juan Xiao
    • Fengqiao Zhou
    • Anbing Zhang

    Original Research Open access 01 August 2023 Pages: 1369 - 1383

    

17. Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis

    • Jessica A. Walsh
    • Christopher D. Saffore
    • Andrew Ostor

    Original Research Open access 12 August 2023 Pages: 1385 - 1398